U.S. Construction Stock News

On June 11, 2026, Victoria’s Secret & Co. announced that shareholders had preliminarily re-elected all nine director nominees, including Independent Chair Donna James, with final voting results to be confirmed in a forthcoming Form 8-K filing. The strong board endorsement underscores investor confidence in management’s “Path to Potential” strategy, which the company says has driven better-than-guided first-quarter 2026 performance and business momentum. We’ll now examine how this clear...

Earlier in June 2026, Herbalife launched its “Fuel Like Ronaldo” campaign with elite footballer Cristiano Ronaldo, offering a simple four-step framework, prepare, perform, recover, repeat, to turn high-performance sports nutrition into everyday wellness guidance. This collaboration signals Herbalife’s push to connect its brand more directly with mainstream fitness and lifestyle consumers by translating elite-level routines into accessible daily habits. We’ll now explore how the “Fuel Like...

Recent analyst upgrades for Nordson (NDSN), tied to strong backlog growth, better-than-expected earnings, and a long record of dividend increases, have drawn more attention to how the stock’s fundamentals line up today. See our latest analysis for Nordson. Nordson’s recent analyst upgrades sit against a solid price backdrop, with the share price at US$295.06 after a 22.42% year to date share price return and a 40.33% 1 year total shareholder return. This suggests momentum has been building as...

Baker Hughes (BKR) drew fresh attention after securing a lifecycle services award from ANOH Gas Processing Company in Nigeria, covering maintenance, repairs and digital monitoring for turbomachinery at the greenfield ANOH Gas Processing Plant. See our latest analysis for Baker Hughes. Recent announcements like the ANOH lifecycle services award and Baker Hughes’s Jefferies Energy Conference appearance have come alongside a 1-year total shareholder return of 59.06%. At the same time, the 30-day...

In recent weeks, CVS Health has expanded its support for GLP-1 medications through new $49 MinuteClinic virtual evaluations, enhanced pharmacy guidance, and participation from July 1, 2026 in the Medicare GLP-1 Bridge program, while also advancing automation, AI-enabled health platforms, sustainability initiatives, and community health partnerships. These moves highlight CVS Health's push to deepen its role in chronic disease management and tech-enabled care, potentially reinforcing its...

Agios Pharmaceuticals recently filed a US$66.16 million shelf registration for 2,000,000 common shares tied to an employee stock ownership plan and, earlier this month, presented 52-week Phase 3 RISE UP data for mitapivat in sickle cell disease at the European Hematology Association Congress. The newly disclosed analyses showed mitapivat was associated with clinically meaningful reductions in transfusion burden and stronger outcomes among hemoglobin responders, adding important detail beyond...

Wayfair (W) is expanding its physical retail presence with a planned large format store in Princeton, New Jersey. This gives investors another data point on how the company is pursuing omnichannel growth. See our latest analysis for Wayfair. Wayfair's latest store announcement comes after a sharp 30 day share price return of 26.79% and a 12.79% gain over 90 days. The year to date share price is down 20.20%, and the 1 year total shareholder return is 74.01%. This suggests recent momentum has...

Global tech stocks are under pressure after sharp sell-offs in Asian markets and renewed doubts about how sustainable the AI boom really is. When fast growing sectors stumble, many investors look more closely at companies in areas like consumer staples, utilities, and healthcare that pay consistent dividends and can sometimes behave differently to high growth tech stocks. This article focuses on three dividend stocks from the Defensive Dividend Stocks screener that appear closely linked to...

Inflation at 4.2%, a 36.6% jump in producer energy costs, and a possible Federal Reserve rate hike by 2026 have put large U.S. growth stocks under a new kind of spotlight. At the same time, easing oil prices and progress in U.S. Iran peace talks could reduce pressure on future rate moves. For investors, this mix of higher rate risk and potential relief creates both opportunity and reasons for caution. This article walks through 3 large cap growth stocks from our screener that appear...

What Morgan Stanley’s Downgrade Signals for Cleveland-Cliffs Stock Morgan Stanley’s downgrade of Cleveland-Cliffs (CLF) from Overweight to Equal-weight, framed around concerns that recent steel price gains and the stock’s valuation already reflect much of the upside, has drawn fresh attention from investors. See our latest analysis for Cleveland-Cliffs. Cleveland-Cliffs’ share price has pulled back recently, with a 3.18% one day decline and a 12.77% drop over the past week. However, the 90...

If you are wondering whether Barrick Mining is still attractively priced after its strong run, this article focuses squarely on what the current share price suggests about value. The stock recently closed at US$40.14, with the share price falling 4.0% over the past week and 1.3% over the past month, but still up 8.9% year to date, 93.8% over the past year, 159.5% over three years, and 123.3% over five years. Recent coverage around Barrick Mining has highlighted company developments and...

AbbVie (NYSE:ABBV) agreed to acquire Apogee Therapeutics in a cash deal valued at about US$10.9b. The transaction is described as AbbVie's largest acquisition in more than five years. The deal adds clinical-stage programs targeting immunology and respiratory diseases, including zumilokibart for atopic dermatitis and asthma. For investors watching AbbVie, this US$10.9b move adds fresh attention to its immunology and respiratory disease efforts. The company is acquiring Apogee Therapeutics to...

Reinsurance Group of America, Incorporated recently announced that long‑time executive Laura Cockrill has been appointed Chief Financial Officer effective June 22, 2026, succeeding Axel André, who resigned and will depart on July 17 after more than two decades of internal experience prepared her for this role. Cockrill’s deep background across capital, investments, collateral, treasury, and financial planning and analysis suggests meaningful continuity in how RGA manages its balance sheet...

The Wendy's Company recently announced that Chief Accounting Officer Suzanne M. Thuerk will resign in July 2026, with long-time tax executive and certified public accountant Aaron M. Kale assuming the principal accounting officer role after years of leadership across the company's tax and accounting functions. At the same time, Wendy's faces pressure from weaker traffic, tighter margins, and potential ingredient cost increases, raising questions about how leadership changes and cost...

Intel (NasdaqGS:INTC) and United Microelectronics Corporation have agreed to jointly develop 12nm and 3nm chip manufacturing processes. The collaboration will use Intel’s Arizona facilities as part of the company’s IDM 2.0 foundry strategy. The partnership aims to support Intel’s foundry capacity utilization and UMC’s return to advanced chip manufacturing. Intel is pushing further into the contract chipmaking business through its IDM 2.0 plan, and this new partnership with UMC fits directly...

If you are wondering whether NIKE stock is starting to look interesting at current levels, the key question is how its current share price stacks up against a grounded view of fair value. Despite NIKE's strong brand, the stock has declined 4.4% over the past week, 3.3% over the past month, and is down 31.7% year to date and 27.0% over the last year. These moves come as the market continues to reassess expectations around consumer demand and the broader athletic apparel sector. This directly...

Earlier in 2026, Precigen received FDA orphan drug exclusivity for PAPZIMEOS, a precision therapy for adult recurrent respiratory papillomatosis, granting seven years of market protection against similar treatments. This exclusivity, underpinned by ASCO data showing many patients remaining surgery-free for at least three years, strengthens PAPZIMEOS’s differentiation in a previously surgery-dependent disease. We’ll now examine how PAPZIMEOS’s seven-year orphan exclusivity could reshape...

ACADIA Pharmaceuticals (ACAD) has drawn fresh attention after filing a shelf registration for up to 5,209,670 common shares, valued at about $113.8 million and tied to its employee stock ownership plan. See our latest analysis for ACADIA Pharmaceuticals. Against the backdrop of steady product sales and reaffirmed guidance, ACADIA Pharmaceuticals’ recent 30 day share price return of 4.69% and 90 day share price return of 5.39% contrast with a year to date share price decline of 15.98%, while...

Global Ship Lease (GSL) is back in focus after shareholders approved updated Articles of Incorporation and the company was reported to be planning four new midsize containership orders to replace older, cash-generating vessels. See our latest analysis for Global Ship Lease. Despite the recent approval of new Articles of Incorporation and the reported plan to order four midsize ships, Global Ship Lease’s 1-year total shareholder return of 59.79% contrasts with more muted recent share price...

Micron Technology (NasdaqGS:MU) has entered a multi-year partnership with Anthropic focused on memory and storage solutions for AI workloads. The agreement includes co-design of next-generation AI memory architectures tailored to Anthropic’s Claude models. Micron is set to become Anthropic’s primary supplier under multi-year memory and storage supply arrangements. Micron plans to adopt Anthropic’s Claude AI models across its enterprise operations. The partnership includes a direct investment...

Charles Schwab (SCHW) is drawing attention after reporting record core net new assets of $49.9b in May 2026 and expanding its digital platforms with 24/7 crypto futures trading along with upcoming binary options. See our latest analysis for Charles Schwab. Despite the product launches and record asset gathering, Charles Schwab’s 1-year total shareholder return of 5.45% contrasts with a declining 9.39% year to date share price return. This suggests recent momentum has cooled after very strong...

Recent Share Performance and Business Scale Johnson Controls International (NYSE:JCI) has seen its stock return 2.3% over the past day, 1.5% over the past week, and gains over the past month, past 3 months, year to date, and past year. The company reports annual revenue of US$24.4b and net income of US$2.0b, with recent annual revenue and net income growth figures available. These provide investors with concrete numbers to assess current scale and profitability. By region, Johnson Controls...

Snowflake (NYSE:SNOW) has released its Modern Marketing Data Stack 2026 report. The report highlights partners such as RudderStack, IPinfo, Tealium, Ketch, Narrative I/O, Verato, Adstra, and DAS42. These partners are recognized for using Snowflake's AI Data Cloud for AI-driven marketing, privacy, and identity solutions. Snowflake enters this news cycle with its shares at $226.59 and a mixed recent track record. The stock is up 31.6% over the past 30 days and 6.0% over the past year, while...

Cloudflare Stock Performance Snapshot Cloudflare (NET) has drawn investor interest after recent price moves, with the stock last closing at US$218.38. Short term returns were mixed, including a 2.5% decline over 1 day and a 7.4% decline over the past week. See our latest analysis for Cloudflare. While Cloudflare’s share price is down over the past week, the 30 day share price return of 1.0% and year to date share price return of 11.4% sit alongside a 1 year total shareholder return of 18.8%...